Wencke Weisner

Title: Wencke Weisner: Innovator in Cancer Treatment

Introduction

Wencke Weisner is a prominent inventor based in Bremen, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel therapeutic methods. Her work focuses on the use of bispecific antibodies and non-cross-blocking antibodies to target tumors effectively.

Latest Patents

Wencke Weisner holds a patent for her invention titled "Methods and antibodies for treating cancer." This patent describes novel methods for the treatment of tumors, which involve the administration of a bispecific antibody or a combination of two or more non-cross-blocking antibodies that recognize the same target antigen or antigenic complex. The invention particularly emphasizes a method for inducing complement-mediated cell killing in tumor treatment, which includes the combined administration of a first antibody and a second antibody to a human being in need.

Career Highlights

Wencke Weisner is associated with Genmab A/S, a leading biotechnology company specializing in the development of innovative antibody therapeutics for the treatment of cancer. Her work at Genmab has been instrumental in advancing cancer therapies and improving patient outcomes.

Collaborations

Wencke has collaborated with notable professionals in her field, including Jan Van De Winkel and Paul Parren. These collaborations have further enhanced her research and contributed to the development of effective cancer treatments.

Conclusion

Wencke Weisner's innovative work in cancer treatment exemplifies her dedication to improving therapeutic options for patients. Her contributions through patents and collaborations highlight her role as a key figure in the biotechnology industry.